Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anders Svedmyr"'
Autor:
Anders Svedmyr, Joakim Hedov, Miklos Lipcsey, Mats Wallin, Magnus Hallbäck, Per-Arne Lönnqvist, Jacob Karlsson
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Sepsis continues to be a major cause of death and illness globally, posing significant challenges for healthcare professionals. In the pursuit of more accurate and timely monitoring tools, the concept of capnodynamically derived mixed venous
Externí odkaz:
https://doaj.org/article/dea70ca3f2df4a3981cbacc204aede2d
Publikováno v:
Intensive Care Medicine Experimental, Vol 12, Iss 1, Pp 1-9 (2024)
Abstract Background Respiratory quotient (RQ) is an important variable when assessing metabolic status in intensive care patients. However, analysis of RQ requires cumbersome technical equipment. The aim of the current study was to examine a simplifi
Externí odkaz:
https://doaj.org/article/03c0cb566f5c475e9e38f8a19b7fe987
Autor:
Magnus Hallbäck, Mark Konrad, Mats Wallin, Jacob Karlsson, Anders Svedmyr, Per-Arne Lönnqvist
Publikováno v:
Journal of Clinical Monitoring and Computing
Mixed venous oxygen saturation (SvO2) is an important variable in anesthesia and intensive care but currently requires pulmonary artery catheterization. Recently, non-invasive determination of SvO2 (Capno-SvO2) using capnodynamics has shown good agre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1e3013895181fad5b76d9df51c581c
http://europepmc.org/articles/PMC8490846
http://europepmc.org/articles/PMC8490846
Autor:
Magnus Hallbäck, Marion Wiegele, Anders Svedmyr, Mats Wallin, Jacob Karlsson, Per-Arne Lönnqvist
Publikováno v:
Anesthesia & Analgesia. 134:644-652
Background The objective of this study was to compare esophageal Doppler cardiac output (COEDM) against the reference method effective pulmonary blood flow cardiac output (COEPBF), for agreement of absolute values and ability to detect change in card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cb5ffe84bbe9d9fbbcc9c5224dc4284
https://doi.org/10.1213/ane.0000000000005679
https://doi.org/10.1213/ane.0000000000005679
Publikováno v:
Paediatric anaesthesia. 32(10)
The protease inhibitor, ritonavir, is a strong inhibitor of CYP 3A. The drug is used for management of the human immunovirus and is currently part of an oral antiviral drug combination (nirmatrelvir-ritonavir) for the early treatment of SARS-2 COVID-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06d6c1a99ef3a23415e2859da9f9b247
https://pubmed.ncbi.nlm.nih.gov/35842922
https://pubmed.ncbi.nlm.nih.gov/35842922